CFChao Feng

Chao Feng

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Chao Feng has a total of 17 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Publisher Correction: Continual integration of single-cell multimodal data with MIRACLE

    by Jiahao Zhou, Jing Wang, Shuofeng Hu, Tongtong Kan, Chao Feng, Xiaohan Qiang, Guohua Dong, Jinhui Shi, Runyan Liu, Xiaochen Bo, et al.

  • Open Access

    Continual integration of single-cell multimodal data with MIRACLE

    by Jiahao Zhou, Jing Wang, Shuofeng Hu, Tongtong Kan, Chao Feng, Xiaohan Qiang, Guohua Dong, Jinhui Shi, Runyan Liu, Xiaochen Bo, et al.

    Single-cell sequencing has transformed our understanding of cellular heterogeneity, enabling the construction of multi-omics atlases through data integration. However, conventional atlas updates require full reintegration of all datasets, creating scalability challenges that limit the timeliness and adaptability of biomedical research. Here we present multimodal integration with continual learning (MIRACLE), an online learning framework for scalable multimodal integration. Using dynamic architecture adaptation and data rehearsal, MIRACLE continually integrates diverse datasets while preserving biological fidelity. Across evaluations, MIRACLE achieves accurate online integration with substantially improved efficiency, refining and expanding atlases with new cross-modal, cross-tissue and cross-disease data. Applied to respiratory infections, it reveals both shared and pathogen-specific immune mechanisms in coronavirus disease 2019, influenza A and tuberculosis. Overall, MIRACLE provides an efficient and collaborative solution for the continual integration, sharing and exploration of biological knowledge.

  • Integrative single-cell transcriptome analysis reveals immune suppressive landscape in the anaplastic thyroid cancer

    by Chao Feng, Yujia Tao, Chao Yu, Lirui Wang, Xiao Liu, Yuan Cao

    The tumor immune microenvironment (TIME) in ATC is a complex and diverse ecosystem. It is essential to have a comprehensive understanding to improve cancer treatment and prognosis. However, TIME of ATC and the dynamic changes with PTC has not been revealed at the single-cell level. Here, we performed an integrative single-cell analysis of PTC and ATC primary tumor samples. We found that immunosuppressive cells and molecules dominated the TIME in ATC. Specifically, the level of infiltration of exhausted CD8+ T cells, and M2 macrophages was increased, and that of NK cells, B cells, and M1 macrophages was decreased. The cytotoxicity of CD8+ T cells, γδT cells, and NK cells was decreased, and immune checkpoint molecules, such as LAG3, PD1, HAVCR2, and TIGIT were highly expressed in ATC. Our findings contribute to the comprehension of TIME in both PTC and ATC, offering insights into the immunosuppressive factors specifically associated with ATC. Targeting these immunosuppressive factors may activate the anti-tumor immune response in ATC.